BioPharma Credit (BPCR) announced its annual results for the year end 31 December 2024. The company generated net income per share of 9.99 cents and paid 10.18 cents in dividends, 3 cents above target. It reported net income return from ordinary activities of $122m. On 31 December 2024, the company’s shares closed at a share … Continue reading Active year for BioPharma Credit